The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, Yi P, Pan Q, Rao S, Han Y, Tang Y, Su M, Luo X, Yang Y, Chen X, Yang L, Zhou Y, Liao Q.
Oncogene. 2022 Feb;41(7):1024-1039. doi: 10.1038/s41388-021-02148-y. Epub 2022 Jan 8.
PMID:34997215
Management of malignant colon polyps: current status and controversies.
Aarons CB, Shanmugan S, Bleier JI.
World J Gastroenterol. 2014 Nov 21;20(43):16178-83. doi: 10.3748/wjg.v20.i43.16178.
PMID:25473171
The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.
Weaver L, Boatman S, Kohn J, Mott SL, Gaertner WB, Madoff RD, Melton GB, Shaukat A, Hassan I, Goffredo P.
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Yin J, Guo Y.
Cancer Med. 2021 Aug;10(16):5524-5533. doi: 10.1002/cam4.4078. Epub 2021 Jul 17.
PMID:34272834
Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment.
Banerjee A, Chabria Y, Kanna N R R, Gopi J, Rowlo P, Sun XF, Pathak S.
Adv Exp Med Biol. 2021;1341:177-192. doi: 10.1007/5584_2019_355.
PMID:30969400
Exosomes derived from microRNA-129-5p-modified tumor cells selectively enhanced suppressive effect in malignant behaviors of homologous colon cancer cells.